In children with a BMI at the 95th percentile or greater, it is important to assess for potential metabolic complications associated with obesity. The correct option is comprehensive, including tests that evaluate lipid profiles, liver function, and glucose metabolism.
The fasting lipid panel is essential in identifying dyslipidemia, which is common among children with obesity and increases the risk of cardiovascular disease. Liver function tests, specifically AST (aspartate aminotransferase) and ALT (alanine aminotransferase), are crucial because non-alcoholic fatty liver disease (NAFLD) is frequently seen in obese children. Monitoring fasting glucose is important as well, as it helps in screening for insulin resistance and prediabetes, which can progress to type 2 diabetes.
Including BUN (blood urea nitrogen) and creatinine (Cr) provides valuable information regarding kidney function, an aspect that can be affected in obese children, especially if they develop metabolic syndrome. Therefore, the comprehensive panel ensures that multiple risk factors associated with obesity are measured, allowing for a more effective evaluation and management strategy.
This group of tests not only helps in understanding the metabolic profile of the child but also assists in guiding appropriate interventions to prevent further complications.